Barings’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-49,892
| Closed | -$4.95M | – | 705 |
|
|
2019
Q3 | $4.95M | Buy |
49,892
+12
| +0% | +$1.14K | 0.11% | 165 |
|
|
2019
Q2 | $4.61M | Sell |
49,880
-18,087
| -27% | -$1.72M | 0.1% | 173 |
|
|
2019
Q1 | $6.41M | Buy |
67,967
+32,100
| +89% | +$2.81M | 0.15% | 117 |
|
|
2018
Q4 | $2.3M | Sell |
35,867
-32,064
| -47% | -$2.37M | 0.04% | 239 |
|
|
2018
Q3 | $6.08M | Buy |
67,931
+20,264
| +43% | +$1.79M | 0.09% | 156 |
|
|
2018
Q2 | $3.79M | Sell |
47,667
-247
| -0.5% | -$20.5K | 0.05% | 223 |
|
|
2018
Q1 | $4.27M | Hold |
47,914
| – | – | 0.06% | 215 |
|
|
2017
Q4 | $5M | Sell |
47,914
-19,410
| -29% | -$2.19M | 0.07% | 206 |
|
|
2017
Q3 | $9.82M | Buy |
67,324
+31,350
| +87% | +$4.27M | 0.18% | 87 |
|
|
2017
Q2 | $4.67M | Sell |
35,974
-27,774
| -44% | -$3.4M | 0.14% | 135 |
|
|
2017
Q1 | $7.93M | Buy |
63,748
+31,874
| +100% | +$3.81M | 0.09% | 218 |
|
|
2016
Q4 | $3.69M | Buy |
31,874
+7,620
| +31% | +$849K | 0.09% | 137 |
|
|
2016
Q3 | $2.54M | Buy |
+24,254
| New | +$2.62M | 0.07% | 222 |
|
|
2016
Q1 | – | Sell |
-40,794
| Closed | -$4.88M | – | 1020 |
|
|
2015
Q4 | $4.88M | Sell |
40,794
-16,750
| -29% | -$1.94M | 0.12% | 101 |
|
|
2015
Q3 | $6.22M | Buy |
57,544
+30,470
| +113% | +$3.78M | 0.15% | 79 |
|
|
2015
Q2 | $3.13M | Sell |
27,074
-13,920
| -34% | -$1.59M | 0.09% | 217 |
|
|
2015
Q1 | $4.73M | Buy |
40,994
+11,890
| +41% | +$1.42M | 0.11% | 134 |
|
|
2014
Q4 | $3.26M | Buy |
29,104
+11,770
| +68% | +$1.24M | 0.07% | 209 |
|
|
2014
Q3 | $1.64M | Buy |
17,334
+2,300
| +15% | +$208K | 0.04% | 354 |
|
|
2014
Q2 | $1.29M | Sell |
15,034
-30,900
| -67% | -$2.35M | 0.04% | 435 |
|
|
2014
Q1 | $3.21M | Sell |
45,934
-32,860
| -42% | -$2.6M | 0.1% | 198 |
|
|
2013
Q4 | $6.66M | Sell |
78,794
-5,080
| -6% | -$402K | 0.28% | 78 |
|
|
2013
Q3 | $6.46M | Buy |
83,874
+13,680
| +19% | +$959K | 0.28% | 76 |
|
|
2013
Q2 | $4.1M | Buy |
+70,194
| New | +$4.22M | 0.18% | 111 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Barings's CELG Position: Q4 2019 in Review
Barings sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 49,892 shares — an estimated $4.95M sold.
Barings first reported a position in CELG in Q2 2013 and held it in 24 quarters. The position peaked at $9.82M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Barings reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Barings sold 49,892 Celgene Corp shares in Q4 2019, an estimated $4.95M.
- Barings first reported a position in Celgene Corp in Q2 2013 and held it in 24 quarters.
- Barings's Celgene Corp position peaked at $9.82M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Barings's 13F filing for Q4 2019, filed 14 Feb 2020.